1. Home
  2. BNC vs CERS Comparison

BNC vs CERS Comparison

Compare BNC & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

HOLD

Current Price

$3.21

Market Cap

287.3M

Sector

Industrials

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.61

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNC
CERS
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
287.3M
276.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BNC
CERS
Price
$3.21
$2.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
233.6K
2.4M
Earning Date
07-24-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
N/A
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
$0.22
N/A
Revenue Growth
N/A
30.68
52 Week Low
$2.39
$1.15
52 Week High
$31.62
$3.15

Technical Indicators

Market Signals
Indicator
BNC
CERS
Relative Strength Index (RSI) 54.94 70.34
Support Level $2.93 $1.78
Resistance Level $4.14 $2.68
Average True Range (ATR) 0.21 0.18
MACD 0.05 0.07
Stochastic Oscillator 73.75 58.46

Price Performance

Historical Comparison
BNC
CERS

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: